… by underlying liver diseases or mediators secreted by primary cancers.[10] [11] … in liver
cancer. We will discuss the preclinical research and the translational implications for liver cancer. …

… liver cancer, and summarize the current status in development of novel liver cancer therapeutic
… underlying the autophagy modulation and liver cancer development may provoke the …

… OS and the pathogenesis of liver cancer has been attracting increasing … liver cancer from
the perspective of cellular and molecular mechanisms and the etiology and therapeutic targets …

… Here we provide a brief review of molecular signaling in liver CSCs and present insights into
new therapeutic strategies for targeting liver CSCs… Therapeutic target of Molecular signaling …

… therapeutic targets for liver cancer. In this review, we focus on the screening of therapeutic
target … against target liver genes identified in our microarray studies. These antibodies kill …

… liver cancer suggesting that antibodies, small molecules, demethylating agents, etc. specifically
acting against molecular target … in HCC as therapeutic targets. Thymidylate synthase (TS) …

… liver cancer therapy was also discussed [68]. To further summarize the current progress in
the study of autophagy in liver cancer… Following this, we then discuss the potential therapeutic …

… One such potential target is lipid metabolism. Altered lipid metabolism has demonstrated a
… novel therapeutic targets for the treatment of HCC. Our review focuses on targets such as …

… of the cellular origin of liver stem/progenitor cells and their relation to liver cancer development,
… markers for liver cancer and, finally, present insights into new therapeutic approaches for …

… cancers has been well defined. Here, we have demonstrated that CD13 is a marker for
semiquiescent CSCs in human liver cancer … therapy may improve the treatment of liver cancer. …